Related Experiment Video
Updated: Jan 29, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma
Ariana N Jacobs1,2, Dominique Jahn2,3, Tim Beringer1,2
1Department of Medicine 2, Hematology/Oncology, University Medical Center Frankfurt, Goethe University, Frankfurt am Main 60590, Germany.
Abstract:
Diffuse large B cell lymphoma (DLBCL) is characterized by a variety of specific genetic alterations that impact signaling pathway dependencies and therapeutic outcomes. Among the recurrently mutated genes, we identified RHOA, a member of the small GTPase family, as a selective dependency in DLBCL. Here, we show that RHOA function is essential for the survival of ABC DLBCL cells because it sustains oncogenic B cell receptor (BCR) signaling through maintaining a signaling-permissive conformation of the cortical actin network. This enables the formation of active BCR microclusters at the cell surface, ultimately resulting in constitutive, BCR-driven NF-κB survival signaling. Moreover, we found that RHOA controlled endocytosis of the BCR and thereby the assembly of the endolysosomal My-T-BCR multiprotein complex, a central activator of NF-κB consisting of MYD88, Toll-like receptor 9, and the internalized BCR. The recurrent DLBCL-associated RHOA R5W mutation rendered RHOA constitutively active in its GTP-bound state and changed the conformation of the actin network from primarily filamentous actin to globular actin. This altered actin state led to an increase in BCR microcluster formation, amplification of NF-κB signaling, and resistance to inhibitors targeting chronic active BCR signaling. Hence, our study establishes RHOA and its mutant isoforms as critical regulators of oncogenic BCR signaling in DLBCL.
Insights
RHOA protein is crucial for diffuse large B cell lymphoma (DLBCL) cell survival by sustaining B cell receptor (BCR) signaling. Mutations in RHOA can amplify this signaling, leading to treatment resistance in DLBCL.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Diffuse large B cell lymphoma (DLBCL) exhibits diverse genetic alterations influencing signaling pathways and treatment responses.
- Identifying specific genetic dependencies is key to understanding DLBCL pathogenesis and developing targeted therapies.
Purpose of the Study:
- To investigate the role of the small GTPase RHOA as a selective dependency in DLBCL.
- To elucidate the mechanisms by which RHOA regulates oncogenic B cell receptor (BCR) signaling in ABC DLBCL cells.
Main Methods:
- Analysis of recurrently mutated genes in DLBCL.
- Functional studies assessing RHOA's impact on cell survival and signaling pathways.
- Investigation of RHOA's role in actin network conformation and BCR microcluster formation.
- Characterization of the RHOA R5W mutation's effects on RHOA activity and BCR signaling.
Main Results:
- RHOA is essential for ABC DLBCL cell survival by sustaining BCR signaling via regulation of the cortical actin network.
- RHOA controls BCR endocytosis and the assembly of the My-T-BCR complex, a key activator of NF-κB signaling.
- The DLBCL-associated RHOA R5W mutation leads to constitutive RHOA activity, altered actin conformation, increased BCR signaling, and resistance to targeted inhibitors.
Conclusions:
- RHOA is a critical regulator of oncogenic BCR signaling in DLBCL.
- RHOA and its mutant isoforms represent potential therapeutic targets for DLBCL treatment.
- Understanding RHOA's function provides insights into DLBCL dependencies and resistance mechanisms.
More Related Videos
Related Concept Videos
Aggression
What is Cell Signaling?
Cell-surface Signaling
Signal Sequences and Sorting Receptors
Insulin: The Receptor and Signaling Pathways
Yeast Signaling

